1. Home
  2. QMMM vs ZNTL Comparison

QMMM vs ZNTL Comparison

Compare QMMM & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QMMM
  • ZNTL
  • Stock Information
  • Founded
  • QMMM 2005
  • ZNTL 2014
  • Country
  • QMMM Hong Kong
  • ZNTL United States
  • Employees
  • QMMM N/A
  • ZNTL N/A
  • Industry
  • QMMM
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • QMMM
  • ZNTL Health Care
  • Exchange
  • QMMM NYSE
  • ZNTL Nasdaq
  • Market Cap
  • QMMM 196.2M
  • ZNTL 227.0M
  • IPO Year
  • QMMM 2024
  • ZNTL 2020
  • Fundamental
  • Price
  • QMMM $0.85
  • ZNTL $2.24
  • Analyst Decision
  • QMMM
  • ZNTL Buy
  • Analyst Count
  • QMMM 0
  • ZNTL 8
  • Target Price
  • QMMM N/A
  • ZNTL $10.50
  • AVG Volume (30 Days)
  • QMMM 1.0M
  • ZNTL 1.6M
  • Earning Date
  • QMMM 02-21-2025
  • ZNTL 02-25-2025
  • Dividend Yield
  • QMMM N/A
  • ZNTL N/A
  • EPS Growth
  • QMMM N/A
  • ZNTL N/A
  • EPS
  • QMMM N/A
  • ZNTL N/A
  • Revenue
  • QMMM $3,510,653.00
  • ZNTL $40,560,000.00
  • Revenue This Year
  • QMMM N/A
  • ZNTL N/A
  • Revenue Next Year
  • QMMM N/A
  • ZNTL N/A
  • P/E Ratio
  • QMMM N/A
  • ZNTL N/A
  • Revenue Growth
  • QMMM 20.09
  • ZNTL N/A
  • 52 Week Low
  • QMMM $0.54
  • ZNTL $2.16
  • 52 Week High
  • QMMM $13.00
  • ZNTL $18.07
  • Technical
  • Relative Strength Index (RSI)
  • QMMM N/A
  • ZNTL 32.61
  • Support Level
  • QMMM N/A
  • ZNTL $2.41
  • Resistance Level
  • QMMM N/A
  • ZNTL $2.93
  • Average True Range (ATR)
  • QMMM 0.00
  • ZNTL 0.28
  • MACD
  • QMMM 0.00
  • ZNTL -0.06
  • Stochastic Oscillator
  • QMMM 0.00
  • ZNTL 6.84

About QMMM QMMM HOLDINGS LIMITED

QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly-owned subsidiaries. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Share on Social Networks: